This Stent Delivery Systems market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape.

NATICK, Mass., Feb. 12, 2013 -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System, the ...

Diseases that affect tubular structures in the body, such as the gastrointestinal (GI) system, vasculature and airway, present a unique challenge for delivering local treatments. Vertically oriented ...

Improving stent implantation techniques has become critical, especially with the advent of new and highly effective stents and delivery systems. The development of new systems with improved ...

Company's third-generation drug-eluting stents now available in rapidly growing market NATICK, Mass., Boston Scientific Corporation today announced its launch of the PROMUS ® Element™ ...

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte® Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug ...

NEW YORK, Oct 21 (Reuters) - Medtronic Inc , which designed the world's first heart pacemaker, said on Tuesday a U.S. court had ordered the lifting of an injunction that had kept it from using a key ...

Diseases that affect tubular structures in the body, such as the gastrointestinal (GI) system, vasculature and airway, present a unique challenge for delivering local treatments. Vertically oriented ...

World's First Transcarotid Stent Delivery System Designed for the Clinically Proven TransCarotid Artery Revascularization (TCAR) Procedure SUNNYVALE, Calif., Silk Road Medical, Inc. announced the ...

Cordis Corporation, part of Cardinal Health, has recalled certain lots of its Precise PRO Rx carotid stent system due to a risk of separation of the distal tip of the sheathed delivery system during ...